12/09 Discover more about cancer of unknown primary in ACT Genomics PCMW

2017-12-09

Identifying more accurate treatment options for cancer of unknown primary (CUP) is one of the first imperatives, since CUP constitutes significant challenges in diagnostic and therapeutic options. The third ACT Genomics Precision Cancer Medicine Workshop, held on 12/09 in Taipei Chang Yung-Fa Foundation, will focus on the case-sharing and treatment experiences of cancer of unknown primary. We invite oncologists from National Taiwan University Hospital, Taipei Veterans General Hospital and ACT Genomics project managers to share accumulated valuable experiences, aiming to assist more oncologists to treat CUP with precision medicine.